Financhill
Back

NovaBay Pharmaceuticals Vs. Triumph Financial Industry Stock Comparison

Sell
43

NBY
NovaBay Pharmaceuticals

Last Price:
$0.64
Seasonality Move:
-3.26%
Sell
41

TFIN
Triumph Financial

Last Price:
$72.55
Seasonality Move:
-2.33%
Sell
43
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.66. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Triumph Financial (TFIN) is a Sell

Is Triumph Financial a Buy, Sell or Hold?

  • The current Triumph Financial [TFIN] share price is $72.57. The Score for TFIN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • TFIN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

TFIN Stock Price Chart

What is Triumph Financial's stock price today?

  • The Triumph Financial share price today is $72.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TFIN is experiencing selling pressure, which indicates risk of future bearish movement.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 49.43 Sell
Chaikin Money Flow: 34267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.65 - 0.73) Sell
Bollinger Bands (100): (0.58 - 0.72) Buy

TFIN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.98 Sell
Relative Strength Index (14 RSI): 28.37 Sell
Chaikin Money Flow: -98144 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (74.36 - 86.8) Sell
Bollinger Bands (100): (78.59 - 99.07) Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Sell
20-day SMA: 0.68 Sell
50-day SMA: 0.63 Buy
200-day SMA: 1.32 Sell
8-day EMA: 0.66 Sell
20-day EMA: 0.67 Sell
50-day EMA: 0.66 Sell
200-day EMA: 3.48 Sell

TFIN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 75.68 Sell
20-day SMA: 78.83 Sell
50-day SMA: 87.91 Sell
200-day SMA: 84.45 Sell
8-day EMA: 75.09 Sell
20-day EMA: 78.63 Sell
50-day EMA: 84.5 Sell
200-day EMA: 84.26 Sell

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.

Triumph Financial Earnings Growth & TFIN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.10 per share, an increase this year of $0.38 per share, and an increase next year of $1.39 per share.

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Triumph Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):